Introduction
Drug Screening Market was valued at USD X.X Billion in 2018 and is projected to reach USD X.X billion by 2025, at a CAGR of X.X % from 2019-2025. Drug screening test analyses biological samples, such as blood, hair, & urine; to diagnose the presence of drug abuse or its metabolites in patient’s body. Drug screening tests are used to determine if person is or was under the influences of drug at a certain point of time.
The global drug screening industry is segmented based on equipment and services, sample type, end user, and geography. Based on equipment and services, the market is divided into immunoassay analyzers, chromatography instruments, breath analyzers, breath analyzers, rapid testing devices, and urine testing devices.
Geographical Overview
At a global level, North America region was holding the highest market share in 2018. Whereas, Asia Pacific region is considered as the fastest growing region with key players adopting expansion strategy in this region to gain maximum market share in the coming years. China and India are offering ample opportunities for the growth of Drug Screening Market with its high population base.
Segmental Overview
Drug Screening Market is segmented as per below specifications -
By Product Type:
• Equipment
• Rapid Testing Devices
• Consumables
• Laboratory Services
By Consumption:
• Urine Sample
• Breath Sample
• Oral Fluid Sample
• Hair Sample
By Distribution Channel:
• Workplace and Schools
• Drug Testing Laboratories
• Criminal Justice System & Law Enforcement Agencies
• Hospitals
• Drug Treatment Centers
Competitor Analysis
Drug Screening Market has presence of some of the key major players across globe which includes
• Alere, Inc.
• Drägerwerk AG & Co.
• KGAA
• Abbott Laboratories
• Hoffmann-La Roche AG
• Biorad Laboratories, Inc.
• Siemens AG
• Thermo Fisher Scientific, Inc.
• Danaher Corporation
These key players are concentrating its efforts on the continuous product improvement with innovative initiatives to have an edge over other competitors. Further, to garner maximum market share, companies are adopting merger/ acquisition/ partnership and maintaining strong distribution networks strategies.
By Geographical Locations:
• North America
o U.S.
o Canada
• Europe
o U.K.
o France
o Italy
o Germany
o Spain
o Russia & CIS
o Rest of Europe
• Asia-Pacific
o China
o India
o Japan
o South Korea
o ASEAN
o Rest of Asia Pacific
• Latin America
o Brazil
o Argentina
o Rest of LATAM
• Middle East & Africa
o UAE
o South Africa
o Rest of MEA
Highlights of the report
What is Drug Screening Market?
Who all are key market players in the industry?
How the Parent Industry is growing?
Where are the key opportunities for new market entrant?
A comprehensive analysis, which covers key growth factors across the value chain
Recent developments in market
Granular Market Segmentation
Market size projection based on Historical & current market trends
Market share analysis and key strategies adopted by leading Players
Production Cost & Sensitivity Analysis
Country Level Market Analysis of Top 16 countries
Data Driven Decision Recommendations
Chapter 1 Research Objective
1.1 Need of the Research Report
1.2 Client Objectives
1.3 Offered Solutions
Chapter 2 Recommendations
2.1 Executive Summary
2.1.1 Market Overview
2.1.2 Competitive Insights
2.1.3 Segmental Analysis
2.1.4 Geographical Market Details
2.2 Lead Generation
2.3 Consultant
2.4 Return on Investment
Chapter 3 Research Methodology
3.1 Chromatus Database
3.2 Paid Sources
3.3 Primary Data Collection
3.3.1 Email Surveys
3.3.2 Telephonic Interviews
3.3.3 Face to Face Interviews
3.4 Secondary Data Collection
3.4.1 Annual Reports
3.4.2 Government Publications
3.4.3 Trade Data
3.4.4 Association Data
3.4.5 Research Papers/ Blogs/ News Articles
3.5 Expert Advisory Panel
3.6 Data Analytics Model
Chapter 4 Drug Screening Market Overview
4.1 Parent Market Overview
4.2 Patent Analysis
4.3 PESTEL Analysis
4.3.1 Political
4.3.2 Economical
4.3.3 Social
4.3.4 Technological
4.3.5 Legal
4.4 SWOT Analysis
4.4.1 Strengths
4.4.2 Weakness
4.4.3 Opportunities
4.4.4 Threats
4.5 Regulations
4.6 Value Chain/ Supply Chain Analysis
4.7 Procurement & Vendor Analysis
4.8 Porters Five Analysis
4.8.1 Threat of new entrants
4.8.2 Bargaining power of suppliers
4.8.3 Bargaining power of buyers
4.8.4 Threat of substitutes
4.8.5 Competitive rivalry
Chapter 5 Regional Analysis Global Drug Screening Market Estimation and Forecast, 2017 - 2025 (USD Billion)
5.1 North America Market
5.1.1 U.S.
5.1.1 Canada
5.2 Europe Market
5.2.1 UK
5.2.2 Germany
5.2.3 France
5.2.4 Spain
5.2.5 Italy
5.2.6 Russia & CIS
5.2.7 Rest of Europe
5.3 Asia Pacific Market
5.3.1 China
5.3.2 Japan
5.3.3 India
5.3.4 South Korea
5.3.5 ASEAN
5.3.6 Rest of Asia Pacific
5.4 Rest of the World
5.4.1 Latin America
5.4.1.1 Brazil
5.4.1.2 Argentina
5.4.1.3 Rest of Latin America
5.4.2 Middle East
5.4.3 Africa
Chapter 6 Company Profile
6.1 Alere, Inc.
6.1.1 Introduction
6.1.2 Financial Overview
6.1.3 Product Portfolio
6.1.4 Recent Developments
6.1.5 SWOT Analysis
6.2 Drägerwerk AG & Co.
6.3 KGAA
6.4 Abbott Laboratories
6.5 Hoffmann-La Roche AG
6.6 Biorad Laboratories, Inc.
6.7 Siemens AG
6.8 Thermo Fisher Scientific, Inc.
6.9 Danaher Corporation
Chapter 7 Competitor Analysis
7.1 Company Ranking
7.2 Key Innovators
7.3 Market Leader
7.4 Emerging Players
7.5 Strategic Alliances
7.6 Competitive Matrix of 12 Companies
Chapter 8 Global Drug Screening Market by Product Type Estimation and Forecast, 2017 - 2025 (USD Billion)
8.1 Equipment
8.2 Rapid Testing Devices
8.3 Consumables
8.4 Laboratory Services
Chapter 9 Global Drug Screening Market by Consumption Type Estimation and Forecast, 2017 - 2025 (USD Billion)
9.1 Urine Sample
9.2 Breath Sample
9.3 Oral Fluid Sample
9.4 Hair Sample
Chapter 10 Global Drug Screening Market by Distribution Channel Estimation and Forecast, 2017 - 2025 (USD Billion)
10.1 Workplace and Schools
10.2 Drug Testing Laboratories
10.3 Criminal Justice System & Law Enforcement Agencies
10.4 Hospitals
Chapter 11 Appendix
11.1 Data Sources
11.2 Abbreviations
11.3 About US
11.4 Disclaimer
11.5 Key Notes
List of Tables
Table 1 Global Drug Screening Market, by Region, 2017 - 2025 (USD Billion)
Table 2 Global Drug Screening Market, by Product Type, 2017 - 2025 (USD Billion)
Table 3 Global Drug Screening Market, by Consumption Type, 2017 - 2025 (USD Billion)
Table 4 Global Drug Screening Market, by Distribution Type, 2017 - 2025 (USD Billion)
Table 5 North America Drug Screening Market 2017 - 2025 (USD Billion)
Table 6 North America Drug Screening Market by Product Type 2017 - 2025 (USD Billion)
Table 7 North America Drug Screening Market by Consumption Type 2017 - 2025 (USD Billion)
Table 8 North America Drug Screening Market by Distribution Type 2017 - 2025 (USD Billion)
Table 9 US Drug Screening Market 2017 - 2025 (USD Billion)
Table 10 Canada Drug Screening Market 2017 - 2025 (USD Billion)
Table 11 Europe Drug Screening Market 2017 - 2025 (USD Billion)
Table 12 Europe Drug Screening Market by Product Type 2017 - 2025 (USD Billion)
Table 13 Europe Drug Screening Market by Consumption Type 2017 - 2025 (USD Billion)
Table 14 Europe Drug Screening Market by Distribution Type 2017 - 2025 (USD Billion)
Table 15 UK Drug Screening Market 2017 - 2025 (USD Billion)
Table 16 Germany Drug Screening Market 2017 - 2025 (USD Billion)
Table 17 France Drug Screening Market 2017 - 2025 (USD Billion)
Table 18 Spain Drug Screening Market 2017 - 2025 (USD Billion)
Table 19 Italy Drug Screening Market 2017 - 2025 (USD Billion)
Table 20 Russia & CIS Drug Screening Market 2017 - 2025 (USD Billion)
Table 21 Rest of Europe Drug Screening Market 2017 - 2025 (USD Billion)
Table 22 Asia Pacific Drug Screening Market 2017 - 2025 (USD Billion)
Table 23 Asia Pacific Drug Screening Market by Product Type 2017 - 2025 (USD Billion)
Table 24 Asia Pacific Drug Screening Market by Consumption Type 2017 - 2025 (USD Billion)
Table 25 Asia Pacific Drug Screening Market by Distribution Type 2017 - 2025 (USD Billion)
Table 26 China Drug Screening Market 2017 - 2025 (USD Billion)
Table 27 Japan Drug Screening Market 2017 - 2025 (USD Billion)
Table 28 India Drug Screening Market 2017 - 2025 (USD Billion)
Table 29 South Korea Drug Screening Market 2017 - 2025 (USD Billion)
Table 30 ASEAN Drug Screening Market 2017 - 2025 (USD Billion)
Table 31 Rest of Asia Pacific Drug Screening Market 2017 - 2025 (USD Billion)
Table 32 Latin America Drug Screening Market 2017 - 2025 (USD Billion)
Table 33 Latin America Drug Screening Market by Product Type 2017 - 2025 (USD Billion)
Table 34 Latin America Drug Screening Market by Consumption Type 2017 - 2025 (USD Billion)
Table 35 Latin America Drug Screening Market by Distribution Type 2017 - 2025 (USD Billion)
Table 36 Brazil Drug Screening Market 2017 - 2025 (USD Billion)
Table 37 Argentina Drug Screening Market 2017 - 2025 (USD Billion)
Table 38 Rest of Latin America Drug Screening Market 2017 - 2025 (USD Billion)
Table 39 Middle East Drug Screening Market 2017 - 2025 (USD Billion)
Table 40 Middle East Drug Screening Market by Product Type 2017 - 2025 (USD Billion)
Table 41 Middle East Drug Screening Market by Consumption Type 2017 - 2025 (USD Billion)
Table 42 Middle East Drug Screening Market by Distribution Type 2017 - 2025 (USD Billion)
Table 43 Africa Drug Screening Market 2017 - 2025 (USD Billion)
Table 44 Africa Drug Screening Market by Product Type 2017 - 2025 (USD Billion)
Table 45 Africa Drug Screening Market by Consumption Type 2017 - 2025 (USD Billion)
Table 46 Africa Drug Screening Market by Distribution Type 2017 - 2025 (USD Billion)
List of Figures
Fig. 1 Primary Research Method
Fig. 2 Secondary Research Method
Fig. 3 Value chain analysis
Fig. 4 PESTEL Analysis
Fig. 5 SWOT Analysis
Fig. 6 Porters Five forces analysis
Fig. 7 Drug Screening Market: Penetration & growth prospect mapping
Fig. 8 Drug Screening Market: Competitive snapshot
Fig. 9 Drug Screening Market: Segmental snapshot
Fig. 10 Market Overview
Fig. 11 Drug Screening Market: Product Analysis, 2017 - 2025
Fig. 12 Drug Screening Market: Regional Analysis, 2017 - 2025
Fig. 13 Drug Screening Market: Competitive Matrix
Fig. 14 Drug Screening Market: Revenue Mix